Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Inventory: 2023-2024

Historic Inventory for Tg Therapeutics (TGTX) over the last 2 years, with Dec 2024 value amounting to $110.5 million.

  • Tg Therapeutics' Inventory rose 73.56% to $147.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.0 million, marking a year-over-year increase of 73.56%. This contributed to the annual value of $110.5 million for FY2024, which is 177.37% up from last year.
  • As of FY2024, Tg Therapeutics' Inventory stood at $110.5 million, which was up 177.37% from $39.8 million recorded in FY2023.
  • In the past 5 years, Tg Therapeutics' Inventory registered a high of $110.5 million during FY2024, and its lowest value of $39.8 million during FY2023.
  • Moreover, its 2-year median value for Inventory was $75.1 million (2023), whereas its average is $75.1 million.
  • Data for Tg Therapeutics' Inventory shows a peak YoY spiked of 177.37% (in 2024) over the last 5 years.
  • Over the past 2 years, Tg Therapeutics' Inventory (Yearly) stood at $39.8 million in 2023, then skyrocketed by 177.37% to $110.5 million in 2024.